Radiochemotherapy for T1G3 bladder cancer.
Dunst
Jürgen
J
Department of Radiotherapy, University of Halle, Germany. juergen.dunst@medizin.uni-halle.de
Rödel
Claus
C
Diestelhorst
Andrea
A
Heynemann
Hans
H
Schrott
Karl Michael
KM
Sauer
Rolf
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001918:Brachytherapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy / Q000379:methods; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D016685:Mitomycin / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
D000970:Antineoplastic Agents; D016685:Mitomycin